Crossref
PRO: Dose-dense Paclitaxel in Combination with Carboplatin is an Acceptable Standard in the Front-Line Management of Advanced Stage Ovarian Cancer
Clinical Ovarian Cancer · 2011
DOI: 10.1016/j.cloc.2011.04.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von Robert L. Coleman. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Coleman, R. L. (2011). PRO: Dose-dense Paclitaxel in Combination with Carboplatin is an Acceptable Standard in the Front-Line Management of Advanced Stage Ovarian Cancer. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2011.04.011
Vancouver
Coleman RL. PRO: Dose-dense Paclitaxel in Combination with Carboplatin is an Acceptable Standard in the Front-Line Management of Advanced Stage Ovarian Cancer. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2011.04.011
BibTeX
@article{Coleman2011,
author = {Coleman, Robert L.},
title = {PRO: Dose-dense Paclitaxel in Combination with Carboplatin is an Acceptable Standard in the Front-Line Management of Advanced Stage Ovarian Cancer},
journal = {Clinical Ovarian Cancer},
year = {2011},
doi = {10.1016/j.cloc.2011.04.011}
}
EUVIMED